No abstract available.
Myeloid Cells*

Myeloid sarcoma (MS) is an uncommon type of malignancy, and its diagnosis is comparable to acute myeloid leukaemia (AML). In the rare circumstances in which MS does present without AML, it is known as MS de novo. We report a case of a 10-month old child who presented with bilateral proptosis and a pelvic mass due to synchronous primary MS de novo. She was initially misdiagnosed with neuroblastoma, which has this typical presentation. The histopathological result from the biopsy of the orbital mass also showed a small blue round cell tumour (SBRCT) as seen in cases of neuroblastoma. However, the diagnosis of MS was confirmed using immunohistochemistry (IHC) from the orbital biopsy specimen, which usually plays a major role in the diagnosis of orbital tumours and as a prognostic indicator. Our patient remains in clinical remission two years after antileukemic treatment, with no relapse or progression to AML.
Myeloid sarcoma

Priapism is a urological emergency. The treatment for ischaemic priapism is usually cavernosal aspiration with or without cavernosal irrigation. Some patients may need surgical intervention -the various shunt procedures. We report a 21-year-old man with priapism secondary to chronic myeloid leukemia who needed a combined medical and surgical management. He underwent a spongiocavernosal shunt as well as cytoreductive chemotherapy to achieve complete detumescence. Therefore, cytoreductive chemotherapy is an adjunct in diffi cult to treat priapism associated with chronic myeloid leukemia
Leukemia, Myeloid

No abstract available.
Leukemia, Myeloid, Acute* ; Sarcoma, Myeloid*

A restrospective study carried out on 309 patients with chronic myelogenous leukemia treated from 1990 to 10/2000 showed that; -88 cases (28.3%) converted to the blast crisis. - 89.77% of these cases developed acute myeloblastic leukemia (AML) and 9.09% developed ALL.-The percentage of male and female were 55.68% and 44.31% - 45.45% of these converted cases occurred in the age group of 30-50. The youngest age was 10 months and the oldest age was : 72 years old. Mean of duration of the chronic phase was 2.5 years.
Leukemia, Myeloid, Chronic ; Leukemia, Myeloid, Chronic-Phase

No abstract available.
Humans ; Leukemia, Myeloid, Acute*

No abstract available.
Leukemia, Myeloid, Acute*

No abstract available.
Leukemia, Myeloid, Acute*

No abstract available.
Humans ; Leukemia, Myeloid, Acute*

A patient with the chronic myeloid leukemia received the autologous stem cells transplantation of peripheral blood. The results have shown that the patient was responded well with the autograft, the graft grew early as estimation. The patient also responded completely with the treatment by Hydrea. The clinical and hematological signs were stable in the long-term. The complication during transplantation was mild. The total survival duration was 75 months.
Leukemia, Myeloid, Chronic ; therapeutics